Recall365
Recalls › Australia › MEDIX Cold & Flu Day & Night & COLES Cold & Flu Day & Night

MEDIX Cold & Flu Day & Night & COLES Cold & Flu Day & Night — recall

Health products · Australia · 2026-10-14

MEDIX and COLES Cold & Flu Day & Night, allergic reaction risk

→ See all Nova Pharmaceuticals Australasia recalls

CountryAustralia
CategoryHealth products
Published2026-10-14
CompanyNova Pharmaceuticals Australasia Pty Ltd
Batch / expiryAll Batches within Expiry
Product typeMedicine
Registration no. (ARTG)353367, 353545
Recall levelConsumer
Hazard classClass I
ReasonSince 2019, listed medicines containing Andrographis paniculata (Andrographis) for supply in Australia have been required to carry a label warning about the risk of allergic reactions including severe reactions such as anaphylaxis. However, despite these warnings, the TGA has continued to receive a sustained high number of reports of anaphylaxis associated with Andrographis-containing listed medicines, which are considered low-risk medicines. Andrographis has now been removed from the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. This means the ingredient is no lon…
Recall typeRecall
RemedyDistributors/Wholesalers • Inspect stock immediately and quarantine all stock of product on hand to prevent further use or distribution. • Return all affected stock on hand with the completed response form to Nova Pharmaceuticals. • Following receipt of returned stock and a completed response form, Nova Pharmaceuticals will contact customers to arrange refund or credit. Consumers • Consumers are advised that if they have the above product, to not use it. • Consumers can return the product to the place of purchase. • If someone is suspected of having anaphylaxis, call for emergency medical he…
Affected areaAustralia
Recall numberRC-2026-RN-00809-1
Official noticeView source ↗

Get alerted when Nova Pharmaceuticals Australasia has another recall

Free: we'll email you when Nova Pharmaceuticals Australasia appears in a new official recall across 11 markets, including the US, EU and Japan.

Watch Nova Pharmaceuticals Australasia recalls — free →

What this means for sellers

Likely platform / channel actionsRetailers/importers typically pull and return stock; similar products may face tighter border checks.
Self-check for comparable productsCheck your comparable products' design, materials and QC records against the defect described here.
Rules & standards likely involvedthe destination market's product-safety rules and mandatory standards

🚨 Delisted or named by a regulator? Leave your details and situation — we'll assess and get back to you. Contact us →

General guidance only — not compliance or legal advice; the official notice and applicable law prevail.

Stay ahead of recalls like this

Get overseas recalls that matter to you (China-origin highlighted) + top hazards — one email a week. Free, unsubscribe anytime.

By subscribing you agree to our Privacy Policy & Terms (incl. cross-border data processing).

Or search & set alerts — free →

Related health products recalls